Growth Metrics

Lemaitre Vascular (LMAT) Gains from Investment Securities (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gains from Investment Securities for 15 consecutive years, with $8.4 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 454.95% to $8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, up 234.45% year-over-year, with the annual reading at $697973.0 for FY2025, 454.68% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $8.4 million at Lemaitre Vascular, up from $741.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $8.4 million in Q4 2025, with the low at -$2.4 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $723141.3, with a median of $741.0 recorded in 2025.
  • The sharpest move saw Gains from Investment Securities soared 6063.0% in 2023, then crashed 139.49% in 2024.
  • Over 5 years, Gains from Investment Securities stood at -$674000.0 in 2021, then soared by 85.16% to -$100000.0 in 2022, then skyrocketed by 6063.0% to $6.0 million in 2023, then plummeted by 139.49% to -$2.4 million in 2024, then soared by 454.95% to $8.4 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $8.4 million, $741.0, and $741.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.